New hope for advanced tumors? first human trial launches

NCT ID NCT06990698

Recruiting now Disease control Sponsor: Zhuhai Fapon Biopharma Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 21 times

Summary

This early-phase study tests a new drug called FP008 in people with advanced solid tumors that have not responded to other treatments. The main goal is to check safety and find the right dose. About 108 adults will take part, and researchers will also look at how the drug works in the body.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hubei Cancer Hospital
RECRUITING

Wuhan, Hubei, 430014, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Shanxi Cancer Hospital
RECRUITING

Taiyuan, Shanxi, 030013, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Zhejiang Cancer Hospital
RECRUITING

Hangzhou, Zhejiang, 310022, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMORS ADVANCED SOLID TUMORS